Assertio (formerly Depomed) is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions. It offers INDOCIN, a non-steroidal anti-inflammatory drug, and CAMBIA, a prescription medicine used to treat migraine attacks. In addition, the company provides ZIPSOR, a non-steroidal anti-inflammatory drug for the treatment of mild to moderate acute pain in adults, and SPRIX, a solution for the management of moderate to moderately severe pain that requires analgesia at the opioid level.